Literature DB >> 6726007

Dose response of cold-adapted, reassortant influenza A/California/10/78 virus (H1N1) in adult volunteers.

B R Murphy, M L Clements, H P Madore, J Steinberg, S O'Donnell, R Betts, D Demico, R C Reichman, R Dolin, H F Maassab.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6726007     DOI： 10.1093/infdis/149.5.816

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  17 in total

1.  Four viral genes independently contribute to attenuation of live influenza A/Ann Arbor/6/60 (H2N2) cold-adapted reassortant virus vaccines.

Authors:  M H Snyder; R F Betts; D DeBorde; E L Tierney; M L Clements; D Herrington; S D Sears; R Dolin; H F Maassab; B R Murphy
Journal:  J Virol       Date:  1988-02       Impact factor: 5.103

2.  Resistance of adults to challenge with influenza A wild-type virus after receiving live or inactivated virus vaccine.

Authors:  M L Clements; R F Betts; E L Tierney; B R Murphy
Journal:  J Clin Microbiol       Date:  1986-01       Impact factor: 5.948

3.  Development and persistence of local and systemic antibody responses in adults given live attenuated or inactivated influenza A virus vaccine.

Authors:  M L Clements; B R Murphy
Journal:  J Clin Microbiol       Date:  1986-01       Impact factor: 5.948

4.  Response of seronegative and seropositive adult volunteers to live attenuated cold-adapted reassortant influenza A virus vaccine.

Authors:  M L Clements; E L Tierney; B R Murphy
Journal:  J Clin Microbiol       Date:  1985-06       Impact factor: 5.948

5.  Live attenuated influenza vaccine strains elicit a greater innate immune response than antigenically-matched seasonal influenza viruses during infection of human nasal epithelial cell cultures.

Authors:  William A Fischer; Kelly D Chason; Missy Brighton; Ilona Jaspers
Journal:  Vaccine       Date:  2014-01-30       Impact factor: 3.641

6.  Attenuation of wild-type human influenza A virus by acquisition of the PA polymerase and matrix protein genes of influenza A/Ann Arbor/6/60 cold-adapted donor virus.

Authors:  M H Snyder; M L Clements; D De Borde; H F Maassab; B R Murphy
Journal:  J Clin Microbiol       Date:  1985-11       Impact factor: 5.948

7.  Safety of and serum antibody response to cold-recombinant influenza A and inactivated trivalent influenza virus vaccines in older adults with chronic diseases.

Authors:  G J Gorse; R B Belshe; N J Munn
Journal:  J Clin Microbiol       Date:  1986-09       Impact factor: 5.948

8.  Effect of simultaneous administration of cold-adapted and wild-type influenza A viruses on experimental wild-type influenza infection in humans.

Authors:  J S Youngner; J J Treanor; R F Betts; P Whitaker-Dowling
Journal:  J Clin Microbiol       Date:  1994-03       Impact factor: 5.948

9.  Development of subtype-specific and heterosubtypic antibodies to the influenza A virus hemagglutinin after primary infection in children.

Authors:  D B Burlington; P F Wright; K L van Wyke; M A Phelan; R E Mayner; B R Murphy
Journal:  J Clin Microbiol       Date:  1985-05       Impact factor: 5.948

10.  Evaluation of cold-recombinant influenza A/Korea (CR-59) virus vaccine in infants.

Authors:  E L Anderson; R B Belshe; B Burk; J Bartram; H F Maassab
Journal:  J Clin Microbiol       Date:  1989-05       Impact factor: 5.948
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.